Tradestie Institutional Equity Comparison Engine

SBC vs ZGM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBC Overall Edge

SBC Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, SBC trades at 9.0x Forward P/E with 39.9% operating margin (+35.1% YoY revenue) versus ZGM at N/M Forward P/E and 31.7% operating margin (-27.0% YoY). In options structure, SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ZGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SBC
SBC 9.0x vs ZGM N/M Fwd P/E
Growth & Margin Winner SBC
Op Margin 39.9% vs 31.7% ยท YoY +35.1% vs -27.0%
Momentum & Technical Winner SBC
1Y +63.6% vs -55.3% ยท 52W Pos 52% vs 16%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SBC NASDAQ
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap $574.4M
1M Return -9.14%
1Y Return +63.61%
Forward P/E 9.0x
Unified AI Score
47.2 / 100 HOLD
Tech 41.0 Fund 36.0 Flow 50.0 Mom 50.0
ZGM NASDAQ
Zenta Group Company Limited Ordinary Shares
Services-Management Consulting Services
$1.65
+7.14% 1D
Market Cap $18.2M
1M Return -10.81%
1Y Return -55.28%
Forward P/E N/M
Unified AI Score
59.4 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SBC +63.61% ZGM -55.28% Spread: +59.69 pp (SBC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SBC TTM Op. Margin: 39.9% ZGM TTM Op. Margin: 31.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBC vs ZGM. Trailing 12-month operating profitability (SBC 39.9% vs ZGM 31.7%) and valuation multiples (SBC 9.0x vs ZGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SBC (7) vs ZGM (3)
Institutional Metric SBC ZGM Criterion Row Winner
Market Capitalization Scale $574.4M $18.2M Larger Scale SBC
Trailing P/E Ratio Valuation 11.0x 15.4x Lower Multiple SBC
Forward P/E Ratio Valuation 9.0x N/M Lower Multiple SBC
Revenue Growth (YoY) Growth +35.1% -27.0% Higher Growth SBC
Operating Margin (TTM) Profitability 39.9% 31.7% Higher Margin SBC
Net Profit Margin Profitability 27.3% 31.7% Higher Margin ZGM
Return on Equity (ROE) Capital Efficiency 19.3% 23.4% Higher ROE ZGM
52-Week Range Position Momentum 52% ($3โ€“$7) 16% ($1โ€“$5) Stronger Trend SBC
Beta / 30D Volatility Risk Regime 0.96ฮฒ ยท 159% Vol 0.88ฮฒ ยท 161% Vol Lower Realized Risk SBC
Unified Institutional Score Composite Signal 47.2 / 100 (HOLD) 59.4 / 100 (HOLD) Higher Composite ZGM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SBC vs ZGM Buy Guide
SBC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SBC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SBC nor ZGM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.